Sonoma Pharmaceuticals (SNOA) Change in Cash (2010 - 2025)

Sonoma Pharmaceuticals' Change in Cash history runs 16 years deep, the most recent figure standing at -$474000.0 for Q4 2025.

• In Q4 2025, Change in Cash fell 140.93% year-over-year to -$474000.0; the TTM figure through Dec 2025 stood at -$2.7 million (down 194.52% YoY), while the FY2025 annual figure was $2.2 million, up 424.57% from the prior year.
• Change in Cash was -$474000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from -$570000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $5.6 million in Q3 2021 to a low of -$2.2 million in Q3 2022.
• Historically, Change in Cash has averaged -$149000.0 across 5 years, with a median of -$506500.0 in 2024.
• Biggest YoY gain for Change in Cash was 2516.02% in 2021; the steepest drop was 3569.44% in 2021.
• A 5-year view of Change in Cash shows it stood at $137000.0 in 2021, then slumped by 623.36% to -$717000.0 in 2022, then soared by 137.52% to $269000.0 in 2023, then surged by 330.48% to $1.2 million in 2024, then plunged by 140.93% to -$474000.0 in 2025.
• The last three Change in Cash figures came in at -$474000.0 (Q4 2025), -$570000.0 (Q3 2025), and -$1.8 million (Q2 2025), per Business Quant data.